… diseases, IPD is a leading cause of morbidity and mortality in children and adults. Vaccination
against pneumococcal infection was … Pneumococcal disease continues to be a problem …

… The collective term invasive pneumococcal disease (IPD) refers to pneumonia, meningitis, …
evidence of pneumococcal infection, but this is achieved for only a minority of cases of IPD. …

… Invasive pneumococcal disease (IPD) remains a major cause of morbidity and mortality
worldwide despite the availability of antibiotic therapy and vaccines. Developing countries bear …

… Since PCV7 introduction, the rate of invasive pneumococcal disease (IPD) among US children
younger than 2 years has decreased by at least 60%. Concurrently, rates of IPD in adults …

… conjugate vaccine (PCV7) have had a significant impact on decreasing the incidence of
serious invasive pneumococcal disease (IPD) in all age groups, especially in children under 2 …

… Invasive pneumococcal disease (IPD) is the leading cause of infectious death worldwide.
This study aimed to describe the epidemiology of IPD and the impact of pneumococcal …

… Invasive pneumococcal disease (IPD) is associated with high morbidity and mortality,
with immunocompromised patients (ICPs) at particular risk. Therefore, guidelines …

… invasive pneumococcal disease (IPD) and pneumococcal serotypes in a population exposed
to limited antibiotic selective pressure and conjugate pneumococcal … data on IPD collected …

… vaccine among risk groups we estimated the increased risk of invasive pneumococcal
disease (IPD) outcomes among clinical risk groups. Three years of post 7-valent …

… invasive disease including bacteremic pneumonia, sepsis and meningitis. In 2015, it was
estimated that pneumoccal pneumonia … , the incidence of invasive pneumococcal disease (IPD) …